Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05496751

Response Variability to Exercise

Response Variability to Exercise in Adults

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Robert Ross, PhD · Academic / Other
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

In this proposal, the investigators challenge the assumption that following the physical activity guidelines implies benefit for ALL adults, and that if benefit is not achieved in response to first line therapy, it will be by simply exercising more. Thus, for improving cardiorespiratory fitness and cardiometabolic risk factors, unanswered questions include: 1) To what extent, regardless of increasing exercise intensity or amount, is exercise not associated with benefit? Demonstration of a resistance to benefit through exercise in a substantial number of adults would be a novel and important finding, would counter the assumptions of many if not most health care practitioners, and could have immediate and direct application in all health care settings. 2) To what extent will non-responders to first line therapy (150 min/wk) be required to increase exercise intensity or amount to achieve benefit? 3) To what extent will failure to improve CRF segregate (be associate with) with cardiometabolic risk factors? The investigators propose that adults who remain exercise resistant for improvement in CRF and cardiometabolic risk despite increasing amount or intensity are at high risk of metabolic disease and consequently, are candidates for alternative treatment strategies.

Detailed description

The trial has two objectives: Primary objective: After 16 weeks of first line therapy (150 min/wk of MPA), does increasing exercise intensity or amount for 16 weeks improve cardiorespiratory fitness (CRF, VO2peak) deferentially depending on the CRF response at 16 weeks. Secondary objective: Determine whether common cardiometabolic risk factors segregate/cluster with respect to variation in CRF to first line therapy in adults, and, whether clinically meaningful improvements in cardiometabolic risk factors segregate with improvement in CRF.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLow amount, low intensity exerciseParticipants will exercise under supervision. Exercise dose will vary by amount and intensity
BEHAVIORALLow amount, high intensity exerciseParticipants will exercise under supervision. Exercise dose will vary by amount and intensity
BEHAVIORALHigh amount, high intensity exerciseParticipants will exercise under supervision. Exercise dose will vary by amount and intensity

Timeline

Start date
2022-09-30
Primary completion
2025-09-30
Completion
2025-09-30
First posted
2022-08-11
Last updated
2025-03-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05496751. Inclusion in this directory is not an endorsement.

Response Variability to Exercise (NCT05496751) · Clinical Trials Directory